Blog

Virtual reality being used to help autistic children conquer their fears

Virtual reality being used to help autistic children conquer their fears
Posted on 11 Mar 2019 by EnViva Paediatric

Autism is a complex condition that often necessitates several different types of support that can help make the individual’s life easier and less stressful to navigate.


Authors urged to show more disabled characters for World Book Day

Authors urged to show more disabled characters for World Book Day
Posted on 7 Mar 2019 by EnViva Paediatric

Authors have been urged to include more characters with disabilities in their stories. Marking World Book Day this week, the Oscar winner Rachel Shenton and Julia Donaldson, author of The Gruffalo, called for more diversity in children’s books.


MMR vaccine does not lead to autism

MMR vaccine does not lead to autism
Posted on 5 Mar 2019 by EnViva Paediatric

Scientists have confirmed that there is no link between the mumps, measles and rubella (MMR) vaccine and autism.


Malnutrition and epilepsy are comorbidities among children with cerebral palsy

Malnutrition and epilepsy are comorbidities among children with cerebral palsy
Posted on 26 Feb 2019 by EnViva Paediatric

A new study has found that malnutrition and epilepsy are two common comorbidities in children with cerebral palsy.


New drug for Duchenne muscular dystrophy clears phase 1 clinical trial testing in boys

New drug for Duchenne muscular dystrophy clears phase 1 clinical trial testing in boys
Posted on 25 Feb 2019 by EnViva Paediatric

Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.


New treatment available on the NHS for children with spinal muscular atrophy

New treatment available on the NHS for children with spinal muscular atrophy
Posted on 19 Feb 2019 by EnViva Paediatric

Recently, families have been given hope of accessing a life-changing treatment on the NHS, which can help slow down the progress of a rare muscle-wasting condition.


New advances for Muscular Dystrophy research

New advances for Muscular Dystrophy research
Posted on 18 Feb 2019 by EnViva Paediatric

A new study by Illinois State University’s Andrés Vidal-Gadea is breaking ground in the field of muscular dystrophy research. 


New research insights hold potential for kids with DMD

New research insights hold potential for kids with DMD
Posted on 12 Feb 2019 by EnViva Paediatric

Experimental drug shows promise for simultaneously treating inflammation and heart disease in trial models. The drug in question called Vamorolone, does so by simultaneously targeting two nuclear receptors important in regulating inflammation and cardiomyopathy


Study urges teens with CP to decrease sedentary habits

Study urges teens with CP to decrease sedentary habits
Posted on 11 Feb 2019 by EnViva Paediatric

Teenagers with cerebral palsy (CP) do not meet the recommendations for healthy weight and physical activity, a study shows. They may also have a high percentage of body fat as well as being inactive.


Growing number of SEND children being home-schooled

Growing number of SEND children being home-schooled
Posted on 5 Feb 2019 by EnViva Paediatric

The Children’s Commissioner for England has warned that 60,000 children are permanently out of school, many of whom are vulnerable or have special educational needs.


Navigation